Company intelligence / Profile preview
Sphaera Pharma
Singapore, Singaporesphaerapharma.com ↗
- Ownership
- Private
- Employees
- ~41
- Development stage
- Preclinical
01
Overview
Sphaera Pharma has established in-house capabilities for all aspects of pre-clinical drug discovery and development. It maintains a balanced portfolio spanning early-stage research through clinical programs targeting unmet medical needs. No detailed public results from late-stage trials are available.
- Therapeutic areas
- Neurology
- Modalities
- Small moleculesDesigner drugsCannabinoidsOpioid antagonists
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Not specifically listed; the CEO attends major industry conventions to expand collaborations.External alliances provide access to specialized services such as radio chemistry, c-GMP manufacturing, GLP studies, structural biology, etc.
Beyond the preview
Go deeper on Sphaera Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sphaera Pharma.